The prevalence of atopic eczema has been regularly increasing for seve
ral decades: over the last 20 years, it has doubled in industrialized
countries to reach 12 to 20%. The relationships between atopic eczema,
asthma and bronchial hyperreactivity have remained vague for a long t
ime and often excessively subjective. Over the last 5 years,tbe public
ation of documented studies therefore encouraged us to re-evaluate the
relationships between atopic dermatitis, asthma and IgE-dependent all
ergy. Eczematous patients appear to have a high risk of developing ast
hma and/or bronchial hyperreactivity: they must therefore be informed
of these risks and should receive preventive measurements, especially
based on a good health education. Subjects suffering from severe eczem
a are usually exposed to a high allergenic load of respiratory allerge
ns, but also to the usual food allergens, all too frequently underesti
mated. In practice, allergological investigation, useless when eczema
is only moderate, is essential in the presence of severe dermatosis. H
owever, in the presence of food sensitization(s), exclusion is only in
dicated after a precise allergological inventory and never on the basi
s of fallacious isolated positive in vitro tests; The natural history
of atopic eczema remains uncertain in individual patients, hence the v
alue of regular clinical surveillance focused on early detection of re
spiratory risks. Attempts to reduce the subsequent atopic risk warrant
further investigation: primary prevention of atopic eczema and second
ary prevention of the other manifestations of atopy (rhinitis and asth
ma) in children already suffering from atopic dermatitis.